BiotechTube

ITIL-306

Phase 1Active
0 watching 0 views this week💤 Quiet
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Epithelial Ovarian Cancer

Conditions

Epithelial Ovarian Cancer, Non-small Cell Lung Cancer, Renal Cell Carcinoma

Trial Timeline

Aug 24, 2022 → Nov 1, 2039

NCT ID
NCT05397093

About ITIL-306

ITIL-306 is a phase 1 stage product being developed by Instil Bio for Epithelial Ovarian Cancer. The current trial status is active. This product is registered under clinical trial identifier NCT05397093. Target conditions include Epithelial Ovarian Cancer, Non-small Cell Lung Cancer, Renal Cell Carcinoma.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05397093Phase 1Active

Competing Products

20 competing products in Epithelial Ovarian Cancer

See all competitors
ProductCompanyStageHype Score
LY2228820 + Carboplatin + Placebo + GemcitabineEli LillyPhase 1/2
41
gemcitabine + carboplatin + paclitaxelEli LillyPhase 2
52
PemetrexedEli LillyPhase 2
52
DE-105 ophthalmic solution + DE-105 ophthalmic solution + Placebo ophthalmic solutionSanten PharmaceuticalPhase 2
52
Mirvetuximab Soravtansine + Paclitaxel + Topotecan + Pegylated liposomal doxorubicinAbbViePhase 3
77
Carboplatin + Mirvetuximab Soravtansine + BevacizumabAbbViePhase 2
52
Mirvetuximab SoravtansineAbbViePhase 2
52
AZD5335 + Mirvetuximab Soravtansine (MIRV) + Paclitaxel + Pegylated liposomal Doxorubicin (PLD) + TopotecanAstraZenecaPhase 3
77
AvelumabAstraZenecaPhase 2
52
Active Comparator: Olaparib tablets + PlaceboAstraZenecaPhase 3
77
Olaparib + carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin + liposomal doxorubicin or liposomal doxorubicin 4-weekly or topotecan or paclitaxel weeklyAstraZenecaPhase 2
52
Olaparib + BevacizumabAstraZenecaApproved
85
Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine + Comparator: Menactra™ (Concomitant) + Comparator: Adacel™ (Concomitant) + Comparator: Menactra™ (Non-concomitant) + Comparator: Adacel™MerckPhase 3
77
PembrolizumabMerckPhase 2
52
MK-1775 and carboplatinMerckPhase 2
52
GardasilMerckPhase 1
33
NG-350A plus PembrolizumabMerckPhase 1
33
Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Current Manufacturing Facility (CMF) + Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Future Manufacturing Facility (FMF) + Comparator: REPEVAX™ (Concomitant) + Comparator: REPEVAX™ (Non-Concomitant)MerckPhase 3
77
V501MerckPhase 3
77
9-valent HPV vaccinationMerckPhase 2
52

Other Products from Instil Bio

ITIL-168Phase 2
44
AXN-2510Phase 1
25
ITIL-168Phase 1
25